Latest News
-
Tohfa, Tohfa, Tohfa: Tata's NBFC To Power; 9 Tata Group Stocks To Pay Massive Dividends In Coming Weeks -
Penny Stock Below Rs 50 Announces Major Update On 6:11 Bonus Shares; Bet? -
Indian Rupee Hits Record Low Amid Middle East Concerns And Fed Rate Speculations -
Gold Rates In UAE: Huge Jump Of Nearly Rs 1,000 In 24-Carat Yellow Metal In Dubai; WHY? -
Nykaa’s Co-founder Adwaita Nayar Named Young Global Leader In WEF’s Class Of 2024 -
2:5 Bonus: Buy Auto Ancillaries Stock Amid Growing Buying Interest, TP Rs 140: Dividend Soon -
6000% Returns In 3 Years: This Multibagger Penny Metal Stock Soars 140% In 12 Months, Hits Record High -
ONGC Stocks Rises 4% On Amid Tensions In Middle East Oil Markets -
2:1 Bonus: Energy Stock Hits 5% Upper Circuit Ahead Of Dividend Recommendations For FY24, Up 509% From Lows -
Gold Price Chennai, April 15: Yellow Metal Prices Jump, Check 22K, 24K Cost
What Is The Best Price To Earnings Ratio At Which To Buy A Share Or Stock?
One of the basic fundamental ratios to analyze whether a share is worth buying and is undervalued is to look at the price to earnings ratio or p/e ratio.
Price to earnings ratio is arrived at by dividing the EPS by the current market price. Read how to calculate and what is p/e ratio
Why P/E ratio is not the best way to analyse a share?
On the other hand PSU banking shares are trading at a p/e of just 6-7 times. Now, if they are trading at such low p/e does it make them attractive buys because they are cheaper.
The answer is probably not. The reason for them are plenty and let's examine them.
Markets look at growth prospects
The future growth potential is of utmost importance to markets. So, if pharma companies are growing at 20-40 per cent, the markets are prepared to pay a hefty premium for them, which is why some pharma shares like Dr Reddys, Glenmark Pharma and Sun Pharma trade at ridiculously high p/e levels.
On the other hand individuals are not ready to buy government banking shares despite a low p/e multiple because of problems with growth, asset quality etc.
Management
Individuals also look at the quality of management and may accord a premium in terms of price to earnings multiples for quality management and companies that are professionally run.
Innovation
Investors would look at future growth through innovation and ingenuity, which is why pharma companies have an edge.
Compare peer within the industry
Some investors tend to compare price to earnings ration of peers within the industry. But, here again one must keep in mind that a company that has expansion plans, a quality management, brand equity and solid track record will command a higher price to earnings ratio.
Therefore, one cannot look at this ratio in isolation.
GoodReturns.in
